Tissue regeneration promotion effects of phenanthroimidazole derivatives through pro-inflammatory pathway activation

Copyright © 2018 Elsevier Ltd. All rights reserved..

A chemotherapeutic drug exerts favorable antitumor activity and simultaneously exhibits expectable inhibition on wound healing process. Phenanthroimidazole derivatives possess potent anticancer activity. However, only a few studies focused on the discovery of its potential effects on promoting tissue regeneration. In this study, four novel phenanthroimidazole derivatives were synthesized and characterized, and they exhibited evident inhibition on different tumor cells; compound 3 is the most active one. Moreover, 3 can promote wound healing of zebrafish in a dose-dependent manner. Further study demonstrated that 3 promoted the recruitment of inflammatory cells, formation of angiogenesis, and generation of reactive oxygen species and also influenced the motor behavior of zebrafish. Results indicated that 3 can accelerate the occurrence of pro-inflammation, angiogenesis, oxidative stress, and innervation, which play key roles in the facilitation of wound healing. Therefore, 3 can act as a bifunctional drug in inhibiting tumor and promoting tissue regeneration.

Medienart:

E-Artikel

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Zur Gesamtaufnahme - volume:80

Enthalten in:

Fish & shellfish immunology - 80(2018) vom: 15. Sept., Seite 582-591

Sprache:

Englisch

Beteiligte Personen:

Lian, Bo-Wen [VerfasserIn]
Wu, Qiong [VerfasserIn]
Zhang, Shuang-Yan [VerfasserIn]
Li, Yu-Mei [VerfasserIn]
Zhao, Xuan-Hao [VerfasserIn]
Mei, Wen-Jie [VerfasserIn]
Wang, Bao-Guo [VerfasserIn]

Links:

Volltext

Themen:

147336-22-9
Anti-tumor
Antineoplastic Agents
Enhanced green fluorescent protein
Green Fluorescent Proteins
Imidazoles
Journal Article
Phenanthroimidazole derivatives
Reactive Oxygen Species
Wound healing
Zebrafish

Anmerkungen:

Date Completed 29.10.2018

Date Revised 29.10.2018

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.fsi.2018.06.029

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM285643002